Browse by Journal Title

Article

Fibrin-targeting molecular MRI in inflammatory CNS disorders.
Lohmeier, J. and Silva, R.V. and Tietze, A. and Taupitz, M. and Kaneko, T. and Prüss, H. and Paul, F. and Infante-Duarte, C. and Hamm, B. and Caravan, P. and Makowski, M.R.
European Journal of Nuclear Medicine and Molecular Imaging 49 (11): 3692–3704. September 2022

Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data.
Schulz, V. and Torres-Espallardo, I. and Renisch, S. and Hu, Z.B. and Ojha, N. and Boernert, P. and Perkuhn, M. and Niendorf, T. and Schaefer, W.M. and Brockmann, H. and Krohn, T. and Buhl, A. and Guenther, R.W. and Mottaghy, F.M. and Krombach, G.A.
European Journal of Nuclear Medicine and Molecular Imaging 38 (1): 138-152. January 2011

Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin's lymphoma: initial experience.
Bienert, M. and Reisinger, I. and Srock, S. and Humplik, B.I. and Reim, C. and Kroessin, T. and Avril, N. and Pezzutto, A. and Munz, D.L.
European Journal of Nuclear Medicine and Molecular Imaging 32 : 1225-1233. 1 January 2005

Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology.
Amthauer, H. and Denecke, T. and Rau, B. and Hildebrandt, B. and Huenerbein, M. and Ruf, J. and Schneider, U. and Gutberlet, M. and Schlag, P.M. and Felix, R. and Wust, P.
European Journal of Nuclear Medicine and Molecular Imaging 31 (6): 811-819. 1 January 2004